Modulation of bone morphogenic protein signaling in T-cells for cancer immunotherapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modulation of bone morphogenic protein signaling in T-cells for cancer immunotherapy
Authors
Keywords
-
Journal
Journal of Immunotoxicology
Volume 11, Issue 4, Pages 319-327
Publisher
Informa UK Limited
Online
2013-12-19
DOI
10.3109/1547691x.2013.864736
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
- (2012) Suzanne L Topalian et al. CURRENT OPINION IN IMMUNOLOGY
- Structural studies of the TGF-βs and their receptors - insights into evolution of the TGF-β superfamily
- (2012) Andrew P. Hinck FEBS LETTERS
- Immunology beats cancer: a blueprint for successful translation
- (2012) Drew M Pardoll NATURE IMMUNOLOGY
- Tumor associated regulatory dendritic cells
- (2012) Yang Ma et al. SEMINARS IN CANCER BIOLOGY
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Comprehensive analysis of TGF-β and BMP receptor interactomes
- (2011) Mohammad Poorgholi Belverdi et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Differential effects of inhibition of bone morphogenic protein (BMP) signalling on T-cell activation and differentiation
- (2011) Yumiko Yoshioka et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Hic-5 controls BMP4 responses in prostate cancer cells through interacting with Smads 1, 5 and 8
- (2011) D T N Shola et al. ONCOGENE
- Tumor-reactive CD4+T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
- (2010) Sergio A. Quezada et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate
- (2010) Ye Zheng et al. NATURE
- Adoptive immunotherapy of cancer using CD4+ T cells
- (2009) Pawel Muranski et al. CURRENT OPINION IN IMMUNOLOGY
- Cell responses to bone morphogenetic proteins and peptides derived from them: Biomedical applications and limitations
- (2009) H. Senta et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Synergistic effect of TGF-β superfamily members on the induction of Foxp3+ Treg
- (2009) Ling Lu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Promising novel immunotherapies and combinations for prostate cancer
- (2009) Philip M Arlen et al. Future Oncology
- TCR Repertoire and Foxp3 Expression Define Functionally Distinct Subsets of CD4+ Regulatory T Cells
- (2009) M. Kuczma et al. JOURNAL OF IMMUNOLOGY
- Activin A Promotes the TGF- -Induced Conversion of CD4+CD25- T Cells into Foxp3+ Induced Regulatory T Cells
- (2009) S. Huber et al. JOURNAL OF IMMUNOLOGY
- Foxp3-Deficient Regulatory T Cells Do Not Revert into Conventional Effector CD4+ T Cells but Constitute a Unique Cell Subset
- (2009) M. Kuczma et al. JOURNAL OF IMMUNOLOGY
- Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor
- (2009) Yann M Kerdiles et al. NATURE IMMUNOLOGY
- Prostate cancer immunotherapy yields superior long-term survival in TRAMP mice when administered at an early stage of carcinogenesis prior to the establishment of tumor-associated immunosuppression at later stages
- (2009) Andrew Gray et al. VACCINE
- Signaling cross-talk between TGF-β/BMP and other pathways
- (2008) Xing Guo et al. CELL RESEARCH
- Regulatory T Cells: Mechanisms of Differentiation and Function
- (2007) Steven Z. Josefowicz et al. Annual Review of Immunology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now